France Genetic Testing Market Insight
The France genetic testing market is expanding at a 10.8% CAGR, driven by increasing precision medicine adoption, rising prevalence of genetic disorders and cancer, growing preventive healthcare awareness, and demand for personalized diagnostic and treatment solutions
France Genetic Testing Market Insights Forecasts to 2035
- The France Genetic Testing Market Size Was Estimated at USD 740.6 Million in 2025
- The Market Size is Expected to Grow at a CAGR of around 10.8% from 2025 to 2035
- The France Genetic Testing Market Size is Expected to Reach USD 2065.03 Million by 2035
Notable Insights for France Genetic Testing Market
- By test type, the predictive and presymptomatic testing segment dominates the market, generating approximately USD 250 million in revenue in 2025, aligned with its majority market share.
- By application, the personalized medicine segment is the fastest-growing, expected to expand at a CAGR of around 11.5% from 2025 to 2035, supported by increasing precision healthcare adoption.
- Approximately 55% of genetic testing demand in France comes from oncology and hereditary disease diagnostics, while nearly 25% involves reproductive and prenatal testing applications.
- Around 30% of market revenue in France is generated by predictive and presymptomatic testing, while nearly 20% comes from pharmacogenomic and personalized medicine applications.
Download the eBook (ToC)
Competitive Analysis:
The report offers the appropriate analysis of the key organizations/companies involved within the France Genetic Testing market, along with a comparative evaluation primarily based on their product of offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Companies in France Genetic Testing Market
- Illumina
- Thermo Fisher Scientific
- Roche Diagnostics
- QIAGEN
- Eurofins Scientific
- Myriad Genetics
- Agilent Technologies
- Bio-Rad Laboratories
- Natera
- Exact Sciences
- Others
Recent Developments:
- In April 2026, Illumina expanded its next-generation sequencing solutions for precision oncology and clinical genomic testing applications across European healthcare institutions.
- In January 2026, Roche Diagnostics enhanced its molecular diagnostic and genomic testing portfolio with AI-supported cancer biomarker analysis technologies.
Market Segmentation:
France Genetic Testing Market, By Test Type
- Predictive & Presymptomatic Testing
- Carrier Testing
- Prenatal & Newborn Testing
- Diagnostic Testing
- Pharmacogenomic Testing
France Genetic Testing Market, By Application
- Oncology
- Rare Genetic Disorders
- Reproductive Health
- Personalized Medicine
- Others
Expert Views:
The France genetic testing market is evolving rapidly with increasing adoption of precision medicine, oncology diagnostics, and personalized healthcare solutions. Experts expect strong long-term growth driven by genomic research advancements, AI-enabled diagnostics, and expanding clinical integration of molecular testing technologies.